The pituitary gland is a vital organ situated at the base of the brain that serves as the master control center for the body’s endocrine system. A pituitary tumour is an abnormal growth that develops within this gland, and while the majority of these growths are benign and non cancerous, they can significantly disrupt the delicate balance of hormones. When these tumours arise from specific cells responsible for producing certain hormones, they can lead to recognizable clinical conditions such as prolactinoma or acromegaly. Understanding the relationship between the type of tumour and the resulting hormone imbalance is essential for accurate diagnosis and effective long term management.
What We’ll Discuss in This Article
- The definition and biological nature of a pituitary tumour or adenoma.
- The classification of tumours based on their size and secretory function.
- The specific mechanism by which lactotroph adenomas cause prolactinoma.
- How somatotroph tumours trigger the development of acromegaly.
- The difference between functioning and non functioning pituitary growths.
- Clinical signs associated with hormone overproduction and mass effects.
- Answers to common questions regarding the management of these conditions.
Understanding pituitary tumours and their types
A pituitary tumour, also known as a pituitary adenoma, is a growth that develops from the cells of the pituitary gland. These tumours are categorized by clinicians in the United Kingdom based on two primary factors: their size and whether they produce active hormones. When a tumour is smaller than 10 millimeters in diameter, it is classified as a microadenoma. If it exceeds this size, it is known as a macroadenoma. While these growths are almost always benign and do not spread to other parts of the body, they can still cause significant health issues by interfering with the gland’s normal functions or by pressing against nearby brain structures such as the optic nerves.
Pituitary tumours are remarkably common, with some clinical studies suggesting that as many as one in ten people may have a small, undiagnosed adenoma that never causes symptoms. However, when these growths become clinically significant, they are usually identified because they either secrete excessive amounts of a specific hormone or they grow large enough to cause “mass effect” symptoms like headaches or visual field defects. The NHS overview of pituitary tumours explains that most of these growths are slow growing and can often be managed successfully through a combination of medication, surgery, or radiotherapy depending on the specific type of cells involved.
How growth hormone secreting tumours lead to acromegaly
Acromegaly is a rare but serious condition that develops when a pituitary tumour, specifically a somatotroph adenoma, produces excessive amounts of growth hormone. In a healthy individual, growth hormone is released in pulses and is essential for maintaining bone and tissue health. However, when a functioning tumour produces a constant surplus, it stimulates the liver to produce another hormone called insulin like growth factor 1. Together, these high levels of hormones cause the soft tissues and bones of the body to grow in an abnormal and exaggerated manner.
Because the physical changes associated with acromegaly occur very slowly, the condition is often not diagnosed until several years after the tumour has started to grow. Patients may notice that their rings no longer fit, or that their shoe size has increased significantly over time. Other symptoms include a coarsening of facial features, a prominent jaw, and gaps appearing between the teeth. According to the NHS guidance on acromegaly, if left untreated, the chronic overproduction of growth hormone can increase the risk of serious complications such as type 2 diabetes, high blood pressure, and heart disease. Management usually involves surgery to remove the adenoma, followed by medication or radiotherapy if hormone levels remain elevated.
Differentiating between functioning and non functioning tumours
It is important to distinguish between “functioning” tumours, which actively produce hormones, and “non functioning” tumours, which do not. Prolactinomas and the somatotroph adenomas that cause acromegaly are both examples of functioning tumours. Because these growths cause specific hormonal symptoms, they are often detected while they are still microadenomas. The patient’s symptoms, such as the cessation of periods or the growth of hands and feet, serve as an early warning system that prompts biochemical testing and subsequent imaging of the pituitary gland.
In contrast, non functioning tumours do not produce hormones that cause a recognizable clinical syndrome. Consequently, they are often not discovered until they have grown large enough to become macroadenomas. These larger tumours can compress the surrounding healthy pituitary tissue, leading to a deficiency in other essential hormones, a condition known as hypopituitarism. They can also exert pressure on the optic chiasm, which is the point where the nerves from the eyes cross over. This pressure can cause a specific type of vision loss where the peripheral or side vision is diminished, often referred to as bitemporal hemianopsia.
The diagnostic pathway for pituitary adenomas
In the United Kingdom, the diagnostic pathway for a suspected pituitary tumour typically begins with a thorough clinical assessment and a series of blood tests. These tests measure the levels of various hormones, including prolactin, growth hormone, and insulin like growth factor 1, as well as the hormones that control the thyroid and adrenal glands. If acromegaly is suspected, a glucose tolerance test may be performed to see if the body can suppress growth hormone production normally. In a healthy person, a sugary drink will cause growth hormone levels to drop, but in someone with a somatotroph adenoma, the levels will remain high.
Once a biochemical abnormality is confirmed, a high resolution MRI scan of the pituitary gland is performed to visualize the location and size of the growth. This allows clinicians to see if the tumour is pressing against the optic nerves or the carotid arteries. Visual field testing is also standard for any patient with a macroadenoma to assess whether their sight has been impacted. This multidisciplinary approach involving endocrinologists, neuroradiologists, and sometimes neurosurgeons ensures that the management plan is tailored to the specific needs of the patient, prioritizing the normalization of hormone levels and the protection of neurological function.
Conclusion
A pituitary tumour is a benign growth that can lead to significant health conditions like prolactinoma or acromegaly by overproducing specific hormones. Prolactinomas result from an excess of prolactin, affecting reproductive health, while acromegaly is caused by a surplus of growth hormone, leading to physical changes and systemic health risks. Early diagnosis through blood tests and imaging is essential to manage these conditions and prevent complications from both hormone levels and the physical size of the tumour. If you experience severe, sudden, or worsening symptoms, call 999 immediately.
Is a pituitary tumour the same as a brain tumour?
While the pituitary gland is located at the base of the brain, a pituitary adenoma is technically a tumour of the endocrine system and is almost always benign, unlike many types of primary brain cancer.
Can a prolactinoma be cured without surgery?
Yes, the majority of prolactinomas are successfully managed with medications called dopamine agonists, which can normalize hormone levels and significantly shrink the size of the tumour.
Why does acromegaly cause joint pain?
The excessive growth hormone leads to the overgrowth of bone and cartilage in the joints, which can cause them to become misaligned and lead to early onset arthritis and chronic discomfort.
Are pituitary tumours inherited?
Most pituitary tumours occur spontaneously, but in a small number of cases, they can be part of a genetic syndrome such as Multiple Endocrine Neoplasia type 1 (MEN1).
What happens if a pituitary tumour is left untreated?
Untreated functioning tumours can lead to serious conditions like heart disease or vision loss, while non functioning tumours may eventually cause the total failure of the pituitary gland.
Does a small microadenoma always require treatment?
Not necessarily; if a microadenoma is non functioning and not causing any symptoms, a doctor may choose to monitor it with periodic scans rather than starting treatment.
Can a pituitary tumour cause weight gain?
Yes, some tumours can cause weight gain indirectly by affecting the thyroid or adrenal glands, or directly if they produce excessive amounts of ACTH leading to Cushing’s disease.
Authority Snapshot
This article provides a clinical overview of the relationship between pituitary tumours, prolactinomas, and acromegaly to support patient education. The content has been authored by a specialized medical content team and reviewed by Dr. Rebecca Fernandez to ensure clinical precision. All information is strictly aligned with the latest NHS guidelines and NICE clinical standards to provide the most reliable and safe information for patients in the United Kingdom.
